Barclays
SVRA icon

Barclays’s Savara SVRA Stock Holding History

Barclays’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,800
Closed -$19.3K – 5472
2024
Q2 		$19.3K Buy
+4,800
New +$21.4K ﹤0.01% 4445

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Barclays's SVRA Position: Q1 2026 in Review

Barclays reduced its Savara (SVRA) stake by 91% in Q1 2026, selling an estimated $1.55M and leaving 27,874 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #3840.

Barclays first reported a position in SVRA in Q4 2015 and has held it in 42 quarters since. The position peaked at $1.85M in Q4 2025. 186 funds tracked by Wall St. Rank hold SVRA as of Q1 2026.

  • Barclays held 27,874 shares of Savara worth $152K as of Q1 2026.
  • Barclays sold 279,066 Savara shares in Q1 2026, an estimated $1.55M.
  • Savara made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3840 holding.
  • Barclays first reported a position in Savara in Q4 2015 and has held it in 42 quarters since.
  • Barclays's Savara position peaked at $1.85M in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Savara as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.